Page last updated: 2024-11-01

niceritrol and Carbohydrate Inducible Hyperlipemia

niceritrol has been researched along with Carbohydrate Inducible Hyperlipemia in 1 studies

Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.

Research Excerpts

ExcerptRelevanceReference
"Niceritrol treatment significantly reduced the Chol/TG ratio in VLDL while no such effect was seen during clofibrate administration."1.26Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease. ( Borberg, J; Gustafsson, IB; Lithell, H; Vessby, B, 1979)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vessby, B1
Lithell, H1
Gustafsson, IB1
Borberg, J1

Other Studies

1 other study available for niceritrol and Carbohydrate Inducible Hyperlipemia

ArticleYear
Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
    Atherosclerosis, 1979, Volume: 33, Issue:4

    Topics: Adult; Aged; Arteriosclerosis; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipopr

1979